Regeneron Pharmaceuticals Fundamental Relationships

REGN -- USA Stock  

Quarterly Earning Report: November 5, 2019  

The Drivers Module shows relationships between Regeneron Pharmaceuticals's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Regeneron Pharmaceuticals over time as well as its relative position and ranking within its peers. Additionally take a look at Your Equity Center

Regeneron Pharmaceuticals Number of Shares Shorted vs. Price to Earnings To Growth Fundamental Analysis

Regeneron Pharmaceuticals is rated third in price to earnings to growth category among related companies. It is rated third in number of shares shorted category among related companies making about  1,194,737  of Number of Shares Shorted per Price to Earnings To Growth.
PEG Ratio indicates potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate.Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates future growth of a firm. The low PEG ratio usually implies that equity instrument is undervalued; where as PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Regeneron Pharmaceuticals 
PEG Ratio 
 = 
PE Ratio 
EPS Growth 
=
1.90 
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Number of Shares Shorted is total amount of shares that are currently sold short by investors. When stock is sold short, the short seller assumes the responsibility of buying the stock back at a lower price. The speculator will make money if the stock goes down in price or will experience loss if the stock price goes up.
Regeneron Pharmaceuticals 
Shares Shorted 
 = 
Shorted by Public 
by Institutions 
=
2.27 M
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect price of the stock.

Regeneron Pharmaceuticals Number of Shares Shorted Comparison

  Number of Shares Shorted 
      Regeneron Pharmaceuticals Comparables 
Regeneron Pharmaceuticals is rated second in number of shares shorted category among related companies.

Regeneron Pharmaceuticals Fundamental Comparison

Search macroaxis.com